Cytodyn Catalyst Calendar
Proactively evaluate Cytodyn Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Cytodyn Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
04 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
15 Oct 2020 | Phase II/III Trial Results | Cytodyn Inc; Mexican National Institute of Public Health; Novant Health Inc | CYDY | leronlimab | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Company Press Release |
01 Sep 2020 | Phase II/III Trial Completion | Amarex Clinical Research LLC; Cytodyn Inc | CYDY | leronlimab | Infectious Disease | Human Immunodeficiency Virus (HIV) Infections (AIDS) | Clinical Trial Registry |
30 Jun 2020 | Phase I/II Trial Results | Amarex Clinical Research LLC; Cytodyn Inc; Quest Clinical Research | CYDY | leronlimab | Oncology | Breast Cancer; Metastatic Breast Cancer; Triple-Negative Breast Cancer (TNBC) | Company Presentation |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer